TELA 8-K 2026-09-29
TELA Bio, Inc. (TELA) 8-K dated 2026-09-29 — accession 0001104659-26-111920.
TELA Bio, Inc. (TELA) is a medical devices company listed on NASDAQ.
TELA Bio, Inc. filed a 8-K on 2026-09-29. Accession 0001104659-26-111920.
This 8-K covers: Material agreement (Item 1.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported TELA revenue for 2025-12-31 was $80.3M. Net income was -$38.8M. Revenue was up 15.8% from 2024-12-31 to 2025-12-31. TELA currently screens at market cap $38.5M.
Not investment advice. The TELA SEC hub lists recent forms. The stock page is the research view.